Efficacy of Lauric Acid, a Dietary Fatty Acid, in Modifying the Latent Reservoir of HIV (FATHIV)

Inclusion Criteria: HIV-1 infected men or women ≥18 years old Not having interrupted current antiretroviral treatment at least 6 months before the screening visit. Acceptable stable ART regimens prior to screening include 2 more NRTIs: INI or NNRTI or boosted PI. Documented prior evidence of at least 2 years prior to enrollment with a serum HIV RNA load of <50 RNA copies/ml (viral load of >50 copies but <200 is allowed). Plasma HIV-1 RNA <50 c/ml at screening visit. CD4 T cell count > 300 cells/µL at screening visit. A woman may be eligible to enroll and participate in the study if: Not pregnant, not of childbearing potential or physically unable to become pregnant You are of childbearing potential with a negative pregnancy test at the screening visit and agree to use contraception to prevent pregnancy. Exclusion Criteria: Have suffered any significant acute illness in the last 8 weeks. Having been diagnosed in the past or present with an AIDS-defining illness Previous CD4 T cell count <200 cells/μL. Having suffered an infection with Hepatitis B or C Having any disease or condition that in the investigator's opinion is not appropriate for the patient's participation in the study.